We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
226
DELISTED
Calavo Growers
CVGW
$1.76M 0.01%
28,023
+456
+2% +$27.3K
NNN icon
227
NNN REIT
NNN
$8.99B
$1.76M 0.01%
49,689
-23,266
-32% -$761K
A icon
228
Agilent Technologies
A
$41.2B
$1.76M 0.01%
19,937
+637
+3% +$52.2K
T icon
229
AT&T
T
$163B
$1.74M 0.01%
76,137
-16,305
-18% -$371K
BBSI icon
230
Barrett Business Services
BBSI
$804M
$1.73M 0.01%
130,224
+1,468
+1% +$17K
SHV icon
231
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$1.71M 0.01%
15,437
+2,925
+23% +$324K
NSC icon
232
Norfolk Southern
NSC
$75.1B
$1.66M 0.01%
9,447
+50
+0.5% +$8.47K
HCSG icon
233
Healthcare Services Group
HCSG
$1.53B
$1.59M 0.01%
65,119
-235
-0.4% -$5.56K
GIS icon
234
General Mills
GIS
$19.7B
$1.59M 0.01%
25,812
-360
-1% -$21.7K
META icon
235
Meta Platforms (Facebook)
META
$1.51T
$1.57M 0.01%
6,936
+65
+0.9% +$13.6K
GPC icon
236
Genuine Parts
GPC
$18.7B
$1.53M 0.01%
17,585
-1,415
-7% -$112K
LIN icon
237
Linde
LIN
$226B
$1.51M 0.01%
7,100
-347
-5% -$67K
WGO icon
238
Winnebago Industries
WGO
$909M
$1.5M 0.01%
22,550
-595
-3% -$30.4K
POOL icon
239
Pool Corp
POOL
$7.5B
$1.47M 0.01%
5,390
+3,086
+134% +$714K
VWO icon
240
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.46M 0.01%
36,786
+1,568
+4% +$58.1K
GILD icon
241
Gilead Sciences
GILD
$165B
$1.44M 0.01%
18,771
+13,848
+281% +$1.06M
CW icon
242
Curtiss-Wright
CW
$25.5B
$1.42M 0.01%
15,876
+251
+2% +$23.9K
ZBH icon
243
Zimmer Biomet
ZBH
$18.4B
$1.31M 0.01%
11,277
-562
-5% -$64.8K
VFC icon
244
VF Corp
VFC
$5.89B
$1.3M 0.01%
21,301
-14,085
-40% -$820K
CCMP
245
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.3M 0.01%
9,295
-174
-2% -$22.5K
WTS icon
246
Watts Water Technologies
WTS
$13.1B
$1.25M 0.01%
15,462
+380
+3% +$30.6K
SJM icon
247
J.M. Smucker
SJM
$12.8B
$1.24M 0.01%
11,685
IBM icon
248
IBM
IBM
$224B
$1.23M 0.01%
10,657
-3,948
-27% -$459K
EOG icon
249
EOG Resources
EOG
$70.7B
$1.21M 0.01%
23,918
-4,100
-15% -$199K
IEX icon
250
IDEX
IEX
$17.3B
$1.2M 0.01%
7,571
+4,089
+117% +$625K

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.